APRE - Aprea Therapeutics dips after pricing $5.5M stock offering
- Aprea Therapeutics ( NASDAQ: APRE ) shares fell over 17% in Wednesday's extended trading after the biopharmaceutical company priced its $5.5M stock offering.
- The offering comprises 1,050,000 shares of its common stock issued at a price of $5.25/share. In addition, the underwriter has been granted a 30-day option to purchase up to an additional 157,500 shares of common stock.
- Net proceeds will be used for the development of Aprea's clinical asset, ATRN-119, its pre-clinical asset ATRN-W1051 and for general corporate purposes.
For further details see:
Aprea Therapeutics dips after pricing $5.5M stock offering